首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Structure of aldehyde reductase in ternary complex with a 5-arylidene-2,4-thiazolidinedione aldose reductase inhibitor.
【24h】

Structure of aldehyde reductase in ternary complex with a 5-arylidene-2,4-thiazolidinedione aldose reductase inhibitor.

机译:具有5-亚芳基-2,4-噻唑烷二酮醛糖还原酶抑制剂的三元复合物中醛还原酶的结构。

获取原文
获取原文并翻译 | 示例
           

摘要

The structure of aldehyde reductase (ALR1) in ternary complex with the coenzyme NADPH and [5-(3-carboxymethoxy-4-methoxybenzylidene)-2,4-dioxothiazolidin-3-yl]acetic acid (CMD), a potent inhibitor of aldose reductase (ALR2), was determined at 1.99A resolution. The partially disordered inhibitor formed a tight network of hydrogen bonds with the active site residues (Tyr50 and His113) and coenzyme. Molecular modelling calculations and inhibitory activity measurements of CMD and [5-(3-hydroxy-4-methoxybenzylidene)-2,4-dioxothiazolidin-3-yl]acetic acid (HMD) indicated that pi-stacking interactions with several conserved active site tryptophan residues and hydrogen-bonding interactions with the non-conserved C-terminal residue Leu300 in ALR2 (Pro301 in ALR1) contributed to inhibitor selectivity. In particular for the potent inhibitor CMD, the rotameric state of the conserved residue Trp219 (Trp220 in ALR1) is important in forming a pi-stacking interaction with the inhibitor in ALR2 and contributes to the difference in the binding of the inhibitor to the enzymes.
机译:醛还原酶(ALR1)与辅酶NADPH和有效的醛糖抑制剂[5-(3-羧基甲氧基-4-甲氧基苄叉基)-2,4-二氧噻唑烷-3-基]乙酸(CMD)三元复合物的结构还原酶(ALR2),以1.99A的分辨率测定。部分无序的抑制剂与活性位点残基(Tyr50和His113)和辅酶形成紧密的氢键网络。 CMD和[5-(3-羟基-4-甲氧基亚苄基)-2,4-二氧噻唑烷-3--3-基]乙酸(HMD)的分子建模计算和抑制活性测量表明,pi堆积相互作用与几个保守的活性位点色氨酸残基以及与ALR2中非保守C端残基Leu300(ALR1中的Pro301)的氢键相互作用有助于抑制剂的选择性。特别是对于有效的抑制剂CMD,保守残基Trp219(ALR1中的Trp220)的旋转状态对于与ALR2中的抑制剂形成pi堆积相互作用非常重要,并且有助于抑制剂与酶的结合不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号